Endicott Biofuels Signs MoU with TransAlgae to Develop Transportation Fuel from Algae

Endicott Biofuels and TransAlgae have signed a development agreement for the production of transportation fuel and renewable feedstock source from algae.

David Robinson, CEO of Endicott Biofuels, said that his company’s aim to produce renewable biofuels from sustainable sources of energy is consistent with TransAlgae's strategy. He added that TransAlgae’s teams have much experience and expertise and that his company is looking forward to working with them to advance the production and commercialization of algae biofuels.

The mission of TransAlgae is to develop a wide variety of commercially viable algae growth platforms for the production of transportation fuels and also for other applications.

Endicott Biofuels, for the past one year, has been engaged in developing a fully flexible model of feedstock development program for the production of biodiesel, which includes the commercialization of algae oil to biodiesel. Endicott has also plans to develop technologies that will offer algae producers more freedom to select algae from different strains for oil extraction for biofuels production.

Endicott Biofuels has produced at a pilot scale, biodiesel of high-quality using 100% lipids from vegetable or animal-based feedstock sources. Through independent testing, the produced biodiesel has been confirmed to exceed all ASTM 6751 biodiesel specifications. Endicott believes this proprietary technology can be used for the production of high-quality biodiesel from algae without any modification in the technology platform.

Dr. Noam Gressel, Co-Founder and Board Member of TransAlgae, said that genetically modified algae provides the best alternate solution for fossil fuels, protein sources, and petro-chemicals without affecting the cultivable land and water.

Source: www.endicottbiofuels.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.